# A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)

> **NCT01090167** · PHASE1 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 14 (actual)

## Conditions studied

- Acute Myelogenous Leukemia

## Interventions

- **DRUG:** clofarabine

## Key facts

- **NCT ID:** NCT01090167
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2014-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01090167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01090167, "A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01090167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*